industry · quantum risk

Is Pharma R&D data Quantum Proof? Industry Quantum Risk

Risk: high · Confidence: high · Reviewed: 2026-07-19

Verdict

Pharma research data paths are not quantum-proof when collaboration channels and archives use classical public-key protection. IP shelf life often exceeds CRQC planning horizons.

Overview

Drug discovery data may need decades of confidentiality. That is a textbook HNDL prioritization case.

Inventory partner portals, cloud research environments, and backup encryption.

Cryptographic profile

Signatures: Research collaboration TLS, IP repository encryption keys, Partner federation
Hash: Dataset integrity seals
Public-key exposure: Long-lived intellectual property and trial data (high HNDL).

Vertical: healthcare

What breaks

Classical-only partner portals for trial data
Backups with classical public-key wraps
Untracked CRO integrations

Mitigations

HNDL classification for R&D datasets
CMK/HSM controls with algorithm tracking
Partner PQC questionnaires

FAQ

Related HNDL page?

/is-quantum-proof/hndl-program

Cloud research?

/industries/cloud and cloud-kms pages

Key concepts (technical dictionary)

Terms used on this page — open a definition:

Full technical dictionary →